Table 2 Study level probability of reaching a clinically meaningful reduction in SGRQ total score according to the magnitude of improvement in FEV1
Improvement in FEV1(mL) | Number of study arms achieving SGRQ reduction, n/N (%) | |
|---|---|---|
| Â | 4 units | 3 units |
≥40 | 17/35 (49) | 21/35 (60) |
≥60 | 14/25 (56) | 18/25 (72) |
≥80 | 12/17 (71) | 14/17 (82) |
≥100 | 12/15 (80) | 14/15 (93) |
≥120 | 8/10 (80) | 9/10 (90) |